SeaStar Medical Holding Corporation (ICU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.46M
Last updated: Nov 17, 2026 at 11:06 AM ET
SeaStar Medical Holding Corporation (ICU) Competitors
The companies most similar to SeaStar Medical Holding are Creative Medical Technology Holdings (CELZ), Cadrenal Therapeutics, Inc. Common Stock (CVKD) and Cardio Diagnostics Holdings (CDIO). By market cap, SeaStar Medical Holding ranks 7th of the 13 companies on this page; Cardio Diagnostics Holdings (CDIO) is the largest at $5.59M.
Peer Comparison
ICU's revenue growth of 82.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| SeaStar Medical Holding (ICU) | $4.46M | N/A | 1.7x | 0.0% | N/A | 82.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.39M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cardio Diagnostics Holdings Inc (CDIO) | $5.59M | N/A | 348.9x | 0.0% | N/A | 25.7% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kiora Pharmaceuticals Inc (KPRX) | $5.44M | N/A | 6.2x | 0.0% | N/A | 0.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Galmed Pharmaceuticals Ltd (GLMD) | $4.95M | N/A | N/A | 0.0% | N/A | 0.0% | N/A |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | $4.63M | N/A | N/A | 0.0% | -90.2% | 0.0% | 0.00% |
| NuCana PLC (NCNA) | $3.88M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Peer median | $4.36M | N/A | 6.2x | 0.0% | -131.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to SeaStar Medical Holding, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated... | CVKD competitors |
| Cardio Diagnostics Holdings Inc (CDIO) | Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions. | CDIO competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Kiora Pharmaceuticals Inc (KPRX) | Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative... | KPRX competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Galmed Pharmaceuticals Ltd (GLMD) | Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. | |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous... | RVPH competitors |
| NuCana PLC (NCNA) | NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. | NCNA competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
Frequently Asked Questions About ICU
Who are SeaStar Medical Holding's main competitors?
The companies most similar to SeaStar Medical Holding include Creative Medical Technology Holdings (CELZ), Cadrenal Therapeutics, Inc. Common Stock (CVKD), Cardio Diagnostics Holdings (CDIO), PharmaCyte Biotech (PMCB) and Kiora Pharmaceuticals (KPRX), listed from the closest match.
Who is SeaStar Medical Holding's biggest competitor?
Cardio Diagnostics Holdings (CDIO) is the largest of the similar companies at $5.59M; Creative Medical Technology Holdings (CELZ) is the closest match by business profile, size, sector and industry.
How does ICU stock compare with its competitors?
ICU's P/S is 1.7x against a peer median of 6.2x; its net margin is 0.0% against a peer median of 0.0%.
Which of SeaStar Medical Holding's competitors pays a higher dividend?
SeaStar Medical Holding pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is SeaStar Medical Holding bigger than its competitors?
No. SeaStar Medical Holding is 7th by market cap among the 13 companies on this page; the largest is Cardio Diagnostics Holdings (CDIO) at $5.59M.
ICU pages: Overview, Earnings, Forecast, Financials, Competitors